NASHVILLE, Tenn. / Mar 25, 2024 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: | HCA Healthcare, Inc. 1Q Earnings Release Call | ||
When: | Friday, April 26, 2024 at 9:00 am central (10:00 am eastern) | ||
How: | Live Audio over the Internet: | ||
https://investor.hcahealthcare.com/events-and-presentations/default.aspx |
Contact:
Frank Morgan, 615-344-2688, Vice President, Investor Relations, This email address is being protected from spambots. You need JavaScript enabled to view it.
If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$406.48 |
| Daily Change: | 5.22 1.30 |
| Daily Volume: | 801,720 |
| Market Cap: | US$104.900B |
October 17, 2024 July 23, 2024 April 26, 2024 April 03, 2024 | |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
